Paying user area
Try for free
Thermo Fisher Scientific Inc. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Thermo Fisher Scientific Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Net profit margin | = | 100 | × | Net income attributable to Thermo Fisher Scientific Inc.1 | ÷ | Revenues1 | |
---|---|---|---|---|---|---|---|
Dec 31, 2024 | = | 100 | × | ÷ | |||
Dec 31, 2023 | = | 100 | × | ÷ | |||
Dec 31, 2022 | = | 100 | × | ÷ | |||
Dec 31, 2021 | = | 100 | × | ÷ | |||
Dec 31, 2020 | = | 100 | × | ÷ | |||
Dec 31, 2019 | = | 100 | × | ÷ | |||
Dec 31, 2018 | = | 100 | × | ÷ | |||
Dec 31, 2017 | = | 100 | × | ÷ | |||
Dec 31, 2016 | = | 100 | × | ÷ | |||
Dec 31, 2015 | = | 100 | × | ÷ | |||
Dec 31, 2014 | = | 100 | × | ÷ | |||
Dec 31, 2013 | = | 100 | × | ÷ | |||
Dec 31, 2012 | = | 100 | × | ÷ | |||
Dec 31, 2011 | = | 100 | × | ÷ | |||
Dec 31, 2010 | = | 100 | × | ÷ | |||
Dec 31, 2009 | = | 100 | × | ÷ | |||
Dec 31, 2008 | = | 100 | × | ÷ | |||
Dec 31, 2007 | = | 100 | × | ÷ | |||
Dec 31, 2006 | = | 100 | × | ÷ | |||
Dec 31, 2005 | = | 100 | × | ÷ |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
- Net Income Attributable to Thermo Fisher Scientific Inc.
- The net income shows a general upward trend from 2005 through 2024, with values increasing from $223 million to $6,335 million. There are some fluctuations, such as a decline in 2006 and 2009, followed by steady growth. Notably, from 2014 to 2021, net income experienced significant growth, peaking at $7,725 million in 2021 before declining in 2022 and 2023, then slightly recovering in 2024.
- Revenues
- Revenues display a consistent growth pattern over the period, rising from $2,633 million in 2005 to $42,879 million in 2024. The growth is steady with minor fluctuations, including a small dip in 2023 relative to the previous year. The largest increases occur between 2014 and 2022, where revenue expands rapidly, implying robust business expansion or acquisitions during those years.
- Net Profit Margin
- The net profit margin exhibits variability, starting at 8.48% in 2005. It decreases in 2006 but generally trends upward with some fluctuations. The margin peaks at 19.79% in 2020, indicating improved profitability relative to revenue during this period. After this peak, there is a decline in 2022 and 2023, with margins falling to approximately 14%, followed by a slight increase in 2024. Overall, the margin improvement over the two decades suggests enhanced operational efficiency or higher margin products/services.
Comparison to Competitors
Thermo Fisher Scientific Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | ||||||||||||
Dec 31, 2023 | ||||||||||||
Dec 31, 2022 | ||||||||||||
Dec 31, 2021 | ||||||||||||
Dec 31, 2020 | ||||||||||||
Dec 31, 2019 | ||||||||||||
Dec 31, 2018 | ||||||||||||
Dec 31, 2017 | ||||||||||||
Dec 31, 2016 | ||||||||||||
Dec 31, 2015 | ||||||||||||
Dec 31, 2014 | ||||||||||||
Dec 31, 2013 | ||||||||||||
Dec 31, 2012 | ||||||||||||
Dec 31, 2011 | ||||||||||||
Dec 31, 2010 | ||||||||||||
Dec 31, 2009 | ||||||||||||
Dec 31, 2008 | ||||||||||||
Dec 31, 2007 | ||||||||||||
Dec 31, 2006 | ||||||||||||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Thermo Fisher Scientific Inc., net profit margin, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Thermo Fisher Scientific Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Dec 31, 2024 | ||
Dec 31, 2023 | ||
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 31, 2019 | ||
Dec 31, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 31, 2014 | ||
Dec 31, 2013 | ||
Dec 31, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 31, 2008 | ||
Dec 31, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Thermo Fisher Scientific Inc., net profit margin, long-term trends, comparison to industry (health care)
Thermo Fisher Scientific Inc. | Health Care | |
---|---|---|
Dec 31, 2024 | ||
Dec 31, 2023 | ||
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 31, 2019 | ||
Dec 31, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 31, 2014 | ||
Dec 31, 2013 | ||
Dec 31, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 31, 2008 | ||
Dec 31, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).